STERIS plc stock tumbles 20% from 2024 peak despite solid earnings
STERIS plc, a leading provider of infection prevention products, has faced a challenging year in the stock market. The company, headquartered in Mentor, Ohio, has seen its share price drop significantly since early 2024. Despite its strong market position and recent revenue growth, the stock continues to trade well below its peak from January 2024.
STERIS plc reached a 52-week high of $269.44 on January 16, 2024. Since then, its stock has fallen sharply, declining by 20.4% from that peak. Over the past six months, shares have dropped by 14.1%, while the past 52 weeks saw a smaller dip of 3.5%.
The company's performance has also lagged behind broader market trends. Over the last three months, STERIS shares fell by 14.8%, compared to a 4.7% decline in the Nasdaq Composite. The stock has remained below both its 200-day and 50-day moving averages since early March and early February, respectively. Despite these struggles, STERIS reported solid financial results for Q3. Revenue came in at $1.50 billion, slightly above analyst expectations of $1.48 billion. Adjusted earnings per share matched forecasts at $2.53. The company, with a market capitalisation of $21 billion, remains a major player in infection prevention, offering sterilizers, surgical equipment, and endoscopy accessories. STERIS is not alone in its downturn. Competitors like Stryker Corporation have also faced declines, though with some variation. Stryker's stock fell 7.4% over the past 52 weeks but performed better than STERIS over six months, with a 12.2% loss. Other sector peers, including DENTSPLY SIRONA and Terumo, have experienced similar pressures due to trade tensions, economic uncertainty, and increased merger activity.
STERIS plc's stock has underperformed both its sector and the broader market in recent months. While the company continues to deliver steady revenue and maintains a strong product portfolio, its share price remains under pressure. The wider medical technology sector faces ongoing challenges from economic instability and industry consolidation.
